Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
02/2001
02/13/2001US6187558 Nucleotide sequence coding enzymatic protein; for development of efficient pesticides in transgenic plants
02/13/2001US6187545 Oligonucleotide sequences associated with the suppression of the activity of phosphenolpyruvate carboxykinase
02/13/2001US6187544 Propagation of nucleotide sequences; prepare nucleotides from messenger ribonucleic acids, separate nucleotide sequences by size, transform cells with nucleotide sequences, mix nucleotide sequences, isolate nucleotides of interest
02/13/2001US6187543 Method of screening a compound for its ability to enhance the ability of tristetraprolin to inhibit tumor necrosis factor
02/13/2001US6187542 Diagnosing humans with congestive heart failure; obtaining leukocyte sample, detecting mutation in gene coding hydrolase, the presence of mutation indicates sensitivity to congestive heart failure
02/13/2001US6187535 Isolating preferential nucleotide sequences coding binding proteins; providing yeast cell mix, mate and plate yeast, isolate diploid yeast, classify nucleotide sequences in diploid yeast cell
02/13/2001US6187534 Methods of evaluating transplant rejection
02/13/2001US6187533 Screening for genome adjustments associated with non-insulin dependent diabetes; obtaining nucleotide sequences from human, analyze nucleotide sequences for genome adjustment, presence of genome adjustment indicates genetic disorders
02/13/2001US6187532 Double-stranded conformational polymorphism analysis
02/13/2001US6187321 A diagnostic kit for detecting the presence of antibodies in a biological sample that specifically bind to an avian e. coli iss polypeptide.
02/13/2001US6187320 Which contain foreign dna elements in addition to the genome sequences necessary for the replication.
02/13/2001US6187319 Administering to the animal an isolated vp6 polypeptide of a second rotavirus sufficient to produce an effective immune response against the first rotavirus, the second rotavirus capable of infecting a different species than the first
02/13/2001US6187308 Ameliorating an immune response disorder.
02/13/2001US6187307 Cancer immunotherapy with semi-allogeneic cells
02/13/2001US6187305 Turning on a gene present in primary cells, secondary cells or immortalized cells of vertebrate origin, which is normally not expressed
02/13/2001US6187287 Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells
02/13/2001US6187214 Method and device for production of components for microfabrication
02/13/2001CA2314595A1 A process for the fermentative preparation of metabolic products and for the nucleotide sequences encoding for the sod gene
02/13/2001CA2173453C Cloned pullulanase
02/13/2001CA2160486C Process for the preparation of immunogens or diagnostic reagents, and immunogens or diagnostic reagents thereby obtainable
02/13/2001CA2150344C Method for producing exogenous protein
02/13/2001CA2127117C Dna encoding a human serotonin receptor (5-ht4b) and uses thereof
02/13/2001CA2079230C Bcrf1 antagonists for treating epstein-barr virus infections
02/13/2001CA2067653C Modified complement system regulator
02/13/2001CA2067334C Recombinant production of lactoperoxidase
02/13/2001CA2067224C Hirudin/polyalkylene glycol conjugates
02/10/2001WO2001032871A2 Follistatin-related protein zfsta4
02/10/2001WO2001007580A1 Thermostable nucleoside diphosphate kinase for nucleic acid detection
02/10/2001CA2389956A1 Follistatin-related protein zfsta4
02/10/2001CA2359070A1 Thermostable nucleoside diphosphate kinase for nucleic acid detection
02/08/2001WO2001009607A1 Microarrays and their manufacture
02/08/2001WO2001009390A1 Tenascin-c nucleic acid ligands
02/08/2001WO2001009389A2 Methods and apparatus for template capture and normalization for submicroliter reaction
02/08/2001WO2001009386A2 Digital amplification
02/08/2001WO2001009385A2 Attachment of oligonucleotides to solid supports through schiff base type linkages for capture and detection of nucleic acids
02/08/2001WO2001009381A2 Methods of nucleic acid analysis by detecting molecular binding events
02/08/2001WO2001009380A1 Transcription-free selex
02/08/2001WO2001009379A1 Antisense modulation of pepck-mitochondrial expression
02/08/2001WO2001009377A1 Method for detecting nucleic acid target sequences involving in vitro transcription from an rna polymerase promoter
02/08/2001WO2001009376A1 Method for amplification of nucleic acids
02/08/2001WO2001009374A2 Method for characterizing nucleic acid fragments
02/08/2001WO2001009364A1 A METHOD TO CONTROL CELLULAR (3R)-HYDROXYACYL-CoA ESTERS, PRECURSOR MOLECULES FOR POLYHYDROXYALKANOATE SYNTHESIS IN GENETICALLY MODIFIED ORGANISMS
02/08/2001WO2001009363A1 Mutant tn5 transposase enzymes and method for their use
02/08/2001WO2001009362A1 Selection for more efficient transformation host cells
02/08/2001WO2001009361A1 Recombinant hsv-1 and live viral vaccines
02/08/2001WO2001009360A1 USE OF RECOMBINANT ADENO-ASSOCIATED VIRUS VECTOR (rAAV) FOR THE PREVENTION OF SMOOTH MUSCLE CELL PROLIFERATION IN A VASCULAR GRAFT
02/08/2001WO2001009359A1 Sink protein
02/08/2001WO2001009358A1 Nucleic acid constructs for the modification of polyamine levels in plants
02/08/2001WO2001009357A2 Ethanol inducible expression system
02/08/2001WO2001009356A1 Mutant gene of the gras family and plants with reduced development containing said mutant gene
02/08/2001WO2001009355A2 PLANT S-ADENOSYLMETHIONIN:Mg-PROTOPORPHYRIN-IX-O-METHYLTRANSFERASE, PLANTS WITH VARIABLE CHLOROPHYLL CONTENTS AND/OR HERBICIDE TOLERANCE, AND METHOD FOR THE PRODUCTION THEREOF
02/08/2001WO2001009354A1 Herbicide resistant transgenic plants with mutated alpha-tubulin
02/08/2001WO2001009353A1 Peroxidase gene sequences from tobacco
02/08/2001WO2001009352A2 Use of aspergillus sojae as host for recombinant protein production
02/08/2001WO2001009351A1 Novel vectors and system for selectable targeted integration of transgenes into a chromosome without antibiotic resistance markers
02/08/2001WO2001009350A2 Genetically engineered bleb vaccine
02/08/2001WO2001009349A1 Gene encoding novel serine protease-like protein
02/08/2001WO2001009348A1 Polypeptides
02/08/2001WO2001009347A2 Archaeal replication accessory factors and methods of use
02/08/2001WO2001009346A1 Gene encoding novel adenylate kinase 3 (ak3)-like protein
02/08/2001WO2001009345A1 Novel genes encoding protein kinase/protein phosphatase
02/08/2001WO2001009344A1 DETECTION OF A GENE, vatD, ENCODING AN ACETYLTRANSFERASE INACTIVATING STREPTOGRAMIN
02/08/2001WO2001009343A1 Nuclease variant and their use in genotyping assays
02/08/2001WO2001009342A1 Microencapsulated nitric oxide synthase source
02/08/2001WO2001009341A2 Method of determining the activity of 1-deoxy-d-xylulose-5-phosphate reductoisomerase and 1-deoxy-d-xylulose-5-phosphate synthase
02/08/2001WO2001009340A1 Proteins derived from white spot syndrome virus and uses thereof
02/08/2001WO2001009339A2 Moraxella catarrhalis antigen basb117
02/08/2001WO2001009338A1 Basb116 dna and proteins from moraxella catarrhalis
02/08/2001WO2001009337A2 Moraxella catarrhalis antigens basb122 and basb124
02/08/2001WO2001009336A1 Basb119 polypeptide and polynucleotide from moraxella catarrhalis
02/08/2001WO2001009335A2 Moraxella catarrhalis antigen basb120
02/08/2001WO2001009334A1 Basb118 polypeptide and polynucleotide from moraxella catarrhalis
02/08/2001WO2001009333A2 Immunogenic polypeptide derived from moraxella catarrhalis and uses thereof
02/08/2001WO2001009332A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof
02/08/2001WO2001009331A2 Moraxella catarrhalis antigen basb125
02/08/2001WO2001009330A2 Moraxella catarrhalis antigen basb121
02/08/2001WO2001009329A1 Basb126 polypeptide and polynucleotide from moraxella catarrhalis
02/08/2001WO2001009328A1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
02/08/2001WO2001009327A2 Method of preventing the injury or death of retinal cells and treating ocular diseases
02/08/2001WO2001009326A1 Constitutively active stat proteins and their uses for identifying modulators of activity including dysproliferative cellular changes
02/08/2001WO2001009325A2 Human p53 mutations and a genetic system in yeast for functional indentification of human p53 mutations
02/08/2001WO2001009324A1 Gene of human brain type pgt
02/08/2001WO2001009323A1 Guanosine triphosphate binding protein-coupled receptors, genes thereof and production and use of the same
02/08/2001WO2001009322A1 Guanosine triphosphate-binding protein coupled receptors, genes thereof and production and use of the same
02/08/2001WO2001009321A1 Gene encoding novel tsp1-like protein
02/08/2001WO2001009320A1 Gene encoding novel adp-ribosylation factor (arf)-like protein
02/08/2001WO2001009319A1 Gene expressed specifically in human fetal heart muscle
02/08/2001WO2001009318A1 Liver cancer-associated genes
02/08/2001WO2001009317A1 Stomach cancer-associated gene
02/08/2001WO2001009316A1 Novel genes encoding protein kinase/protein phosphatase
02/08/2001WO2001009315A1 Novel gene participating in the maintenance of smooth muscle cell differentiation
02/08/2001WO2001009314A1 Novel uses of abca-type transporters
02/08/2001WO2001009313A1 G-protein coupled receptor and dna sequences thereof
02/08/2001WO2001009312A2 Improvements in antisense oligomers, delivery of antisense oligomers, and identification of antisense oligomer targets
02/08/2001WO2001009311A2 Methods of inhibiting cancer cells with adnf iii antisense oligonucleotides
02/08/2001WO2001009310A1 5'ENRICHED cDNA LIBRARIES AND A YEAST SIGNAL TRAP
02/08/2001WO2001009309A2 RESCUE OF MUMPS VIRUS FROM cDNA
02/08/2001WO2001009308A1 Inducible cancer model to study the molecular basis of host tumor cell interactions in vivo
02/08/2001WO2001009307A2 Screen for nitric oxide synthase modulators
02/08/2001WO2001009306A2 Mutant bacterial strains l-lysine production